Barclays’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $901M | Sell |
|
|||||
|
2025
Q1 | $1.17B | Buy |
|
|||||
|
2024
Q4 | $508M | Sell |
|
|||||
|
2024
Q3 | $955M | Buy |
|
|||||
|
2024
Q2 | $751M | Buy |
|
|||||
|
2024
Q1 | $691M | Buy |
|
|||||
|
2023
Q4 | $506M | Sell |
|
|||||
|
2023
Q3 | $570M | Sell |
|
|||||
|
2023
Q2 | $543M | Buy |
|
|||||
|
2023
Q1 | $311M | Sell |
|
|||||
|
2022
Q4 | $564M | Buy |
|
|||||
|
2022
Q3 | $371M | Buy |
|
|||||
|
2022
Q2 | $273M | Sell |
|
|||||
|
2022
Q1 | $448M | Sell |
|
|||||
|
2021
Q4 | $571M | Buy |
|
|||||
|
2021
Q3 | $418M | Buy |
|
|||||
|
2021
Q2 | $331M | Buy |
|
|||||
|
2021
Q1 | $245M | Sell |
|
|||||
|
2020
Q4 | $274M | Sell |
|
|||||
|
2020
Q3 | $430M | Buy |
|
|||||
|
2020
Q2 | $191M | Sell |
|
|||||
|
2020
Q1 | $168M | Sell |
|
|||||
|
2019
Q4 | $282M | Buy |
|
|||||
|
2019
Q3 | $194M | Sell |
|
|||||
|
2019
Q2 | $229M | Buy |
|
|||||
|
2019
Q1 | $239M | Sell |
|
|||||
|
2018
Q4 | $293M | Sell |
|
|||||
|
2018
Q3 | $503M | Buy |
|
|||||
|
2018
Q2 | $357M | Buy |
|
|||||
|
2018
Q1 | $334M | Buy |
|
|||||
|
2017
Q4 | $266M | Buy |
|
|||||
|
2017
Q3 | $124M | Sell |
|
|||||
|
2017
Q2 | $104M | Sell |
|
|||||
|
2017
Q1 | $96.6M | Buy |
|
|||||
|
2016
Q4 | $72M | Buy |
|
|||||
|
2016
Q3 | $59.3M | Sell |
|
|||||
|
2016
Q2 | $74.7M | Buy |
|
|||||
|
2016
Q1 | $63.2M | Buy |
|
|||||
|
2015
Q4 | $64M | Sell |
|
|||||
|
2015
Q3 | $76.7M | Sell |
|
|||||
|
2015
Q2 | $162M | Sell |
|
|||||
|
2015
Q1 | $248M | Buy |
|
|||||
|
2014
Q4 | $244M | Sell |
|
|||||
|
2014
Q3 | $289M | Buy |
|
|||||
|
2014
Q2 | $99.2M | Sell |
|
|||||
|
2014
Q1 | $118M | Sell |
|
|||||
|
2013
Q4 | $123M | Buy |
|
|||||
|
2013
Q3 | $99.4M | Buy |
|
|||||
|
2013
Q2 | $87M | Buy |
|